2026 ICD-10-CM Diagnosis Code T40.493APoisoning by other synthetic narcotics, assault, initial encounter

ICD-10-CM CodesS00–T88T36-T50T40

ICD-10-CM T40.493A
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

T40.493A is a billable ICD-10-CM diagnosis code for poisoning by other synthetic narcotics, assault, initial encounter. The 7th character A marks it as an initial encounter code, used while the patient is receiving active treatment. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 917 through 918. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under External cause codes: intent of injury, assault; External cause codes: poisoning by drug; and Opioid-related disorders.

Code Identity

ICD-10-CM Code
T40.493A
Billable Status
Yes — Valid for Submission
Code Describes
Poisoning by other synthetic narcotics, assault, initial encounter
Short Description
Poisoning by other synthetic narcotics, assault, init
Parent Code
Poisoning by other synthetic narcotics, assault

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT40Poisoning by, adverse effect of and underdosing of narcotics and psychodysleptics [hallucinogens]
This CodeT40.493APoisoning by other synthetic narcotics, assault, initial encounter

Coding GuidelinesGuidance

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined). If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of narcotics and psychodysleptics [hallucinogens] (T40). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR EXT022
External cause codes: intent of injury, assault
Default principal diagnosis: inpatient No · outpatient No
CCSR EXT014
External cause codes: poisoning by drug
Default principal diagnosis: inpatient No · outpatient No
CCSR MBD018
Opioid-related disorders
Default principal diagnosis: inpatient No · outpatient No
CCSR INJ022
Poisoning by drugs, initial encounter
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Alphaprodine

    an opioid analgesic chemically related to and with an action resembling that of meperidine, but more rapid in onset and of shorter duration. it has been used in obstetrics, as pre-operative medication, for minor surgical procedures, and for dental procedures. (from martindale, the extra pharmacopoeia, 30th ed, p1067)
  • Buprenorphine

    a derivative of the opioid alkaloid thebaine that is a more potent and longer lasting analgesic than morphine. it appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. the lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use.
  • Buprenorphine, Naloxone Drug Combination

    a pharmaceutical preparation that combines buprenorphine, an opioid analgesics with naloxone, a narcotic antagonists to reduce the potential for narcotic dependence in the treatment of pain. it may also be used for opioid substitution therapy.
  • Butorphanol

    a synthetic morphinan analgesic with narcotic antagonist action. it is used in the management of severe pain.
  • Dextromoramide

    an opioid analgesic structurally related to methadone and used in the treatment of severe pain. (from martindale, the extra pharmacopoeia, 30th ed, p1070)
  • Dextropropoxyphene

    a narcotic analgesic structurally related to methadone. only the dextro-isomer has an analgesic effect; the levo-isomer appears to exert an antitussive effect.
  • Levopropoxyphene

    a propionate derivative that is used to suppress coughing.
  • Levorphanol

    a narcotic analgesic that may be habit-forming. it is nearly as effective orally as by injection.
  • Meperidine

    a narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor. prolonged use may lead to dependence of the morphine type; withdrawal symptoms appear more rapidly than with morphine and are of shorter duration.
  • Nalbuphine

    a narcotic used as a pain medication. it appears to be an agonist at kappa receptors and an antagonist or partial agonist at mu receptors.
  • Pentazocine

    the first mixed agonist-antagonist analgesic to be marketed. it is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (from ama drug evaluations annual, 1991, p97)
  • Phenazocine

    an opioid analgesic with actions and uses similar to morphine. (from martindale, the extra pharmacopoeia, 30th ed, p1095)
  • Phenoperidine

    a narcotic analgesic partly metabolized to meperidine in the liver. it is similar to morphine in action and used for neuroleptanalgesia, usually with droperidol.
  • Tilidine

    an opioid analgesic used similarly to morphine in the control of moderate to severe pain. (from martindale, the extra pharmacopoeia, 30th ed, p1097)

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect
Under­dosing
AlphaprodineT40.491T40.492T40.493T40.494T40.495T40.496
AnileridineT40.491T40.492T40.493T40.494T40.495T40.496
BezitramideT40.491T40.492T40.493T40.494T40.495T40.496
BuprenorphineT40.491T40.492T40.493T40.494T40.495T40.496
ButorphanolT40.491T40.492T40.493T40.494T40.495T40.496
DextromoramideT40.491T40.492T40.493T40.494
Dextromoramide::topicalT40.491T40.492T40.493T40.494
DextropropoxypheneT40.491T40.492T40.493T40.494T40.495T40.496
DipipanoneT40.491T40.492T40.493T40.494
EptazocineT40.491T40.492T40.493T40.494T40.495T40.496
EthoheptazineT40.491T40.492T40.493T40.494T40.495T40.496
IsonipecaineT40.491T40.492T40.493T40.494T40.495T40.496
KetobemidoneT40.491T40.492T40.493T40.494
LevopropoxypheneT40.491T40.492T40.493T40.494T40.495T40.496
LevorphanolT40.491T40.492T40.493T40.494T40.495T40.496
MeperidineT40.491T40.492T40.493T40.494T40.495T40.496
NalbuphineT40.491T40.492T40.493T40.494T40.495T40.496
PentazocineT40.491T40.492T40.493T40.494T40.495T40.496
PethidineT40.491T40.492T40.493T40.494T40.495T40.496
PhenazocineT40.491T40.492T40.493T40.494T40.495T40.496
PhenoperidineT40.491T40.492T40.493T40.494
PiritramideT40.491T40.492T40.493T40.494
ProfadolT40.491T40.492T40.493T40.494T40.495T40.496
PropoxypheneT40.491T40.492T40.493T40.494T40.495T40.496
TilidineT40.491T40.492T40.493T40.494

Code History & ChangesHistory

Replacement T40.493A replaces the following previously assigned code(s):

  • T40.4X3A - Poisoning by other synthetic narcotics, assault, init encntr
FY 2021AddedAdded to the ICD-10-CM code setEffective October 1, 2020.
FY 2022–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About T40.493AOverview

Is T40.493A (Poisoning by other synthetic narcotics, assault) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report poisoning by other synthetic narcotics, assault, initial encounter on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What does the 7th character A in T40.493A mean?

The final character A marks the initial encounter: use it while the patient is receiving active treatment for poisoning by other synthetic narcotics, assault, such as an emergency visit or first evaluation.

What MS-DRG does T40.493A group to?

When poisoning by other synthetic narcotics, assault, initial encounter is the principal diagnosis on an inpatient stay, it groups to MS-DRG 917, 918, with relative weights from 0.8571 to 1.5684 depending on complications. Higher weights mean higher Medicare reimbursement.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.